These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38758695)

  • 1. An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit
    Kaya P; Schaffner-Reckinger E; Manoharan GB; Vukic V; Kiriazis A; Ledda M; Burgos Renedo M; Pavic K; Gaigneaux A; Glaab E; Abankwa DK
    J Med Chem; 2024 Jun; 67(11):8569-8584. PubMed ID: 38758695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of pyrazolopyridazinones as PDEδ inhibitors.
    Papke B; Murarka S; Vogel HA; Martín-Gago P; Kovacevic M; Truxius DC; Fansa EK; Ismail S; Zimmermann G; Heinelt K; Schultz-Fademrecht C; Al Saabi A; Baumann M; Nussbaumer P; Wittinghofer A; Waldmann H; Bastiaens PI
    Nat Commun; 2016 Apr; 7():11360. PubMed ID: 27094677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling.
    Yelland T; Garcia E; Parry C; Kowalczyk D; Wojnowska M; Gohlke A; Zalar M; Cameron K; Goodwin G; Yu Q; Zhu PC; ElMaghloob Y; Pugliese A; Archibald L; Jamieson A; Chen YX; McArthur D; Bower J; Ismail S
    J Med Chem; 2022 Feb; 65(3):1898-1914. PubMed ID: 35104933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer.
    Leung EL; Luo LX; Li Y; Liu ZQ; Li LL; Shi DF; Xie Y; Huang M; Lu LL; Duan FG; Huang JM; Fan XX; Yuan ZW; Ding J; Yao XJ; Ward DC; Liu L
    Int J Cancer; 2019 Sep; 145(5):1334-1345. PubMed ID: 30786019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas.
    Klein CH; Truxius DC; Vogel HA; Harizanova J; Murarka S; Martín-Gago P; Bastiaens PIH
    Int J Cancer; 2019 Feb; 144(4):767-776. PubMed ID: 30194764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216.
    Teng M; Lu W; Donovan KA; Sun J; Krupnick NM; Nowak RP; Li YD; Sperling AS; Zhang T; Ebert BL; Fischer ES; Gray NS
    J Med Chem; 2022 Jan; 65(1):747-756. PubMed ID: 34965125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer.
    Cheng J; Li Y; Wang X; Dong G; Sheng C
    J Med Chem; 2020 Jul; 63(14):7892-7905. PubMed ID: 32603594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras Activity.
    Siddiqui FA; Alam C; Rosenqvist P; Ora M; Sabt A; Manoharan GB; Bindu L; Okutachi S; Catillon M; Taylor T; Abdelhafez OM; Lönnberg H; Stephen AG; Papageorgiou AC; Virta P; Abankwa D
    ACS Omega; 2020 Jan; 5(1):832-842. PubMed ID: 31956834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo.
    Cruz-Nova P; Schnoor M; Correa-Basurto J; Bello M; Briseño-Diaz P; Rojo-Domínguez A; Ortiz-Mendoza CM; Guerrero-Aguirre J; García-Vázquez FJ; Hernández-Rivas R; Thompson-Bonilla MDR; Vargas M
    BMC Cancer; 2018 Nov; 18(1):1056. PubMed ID: 30382908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells.
    Chen YH; Lv H; Shen N; Wang XM; Tang S; Xiong B; Ding J; Geng MY; Huang M
    Acta Pharmacol Sin; 2020 Feb; 41(2):270-277. PubMed ID: 31316177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.
    Zimmermann G; Papke B; Ismail S; Vartak N; Chandra A; Hoffmann M; Hahn SA; Triola G; Wittinghofer A; Bastiaens PI; Waldmann H
    Nature; 2013 May; 497(7451):638-42. PubMed ID: 23698361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design.
    Chen L; Zhuang C; Lu J; Jiang Y; Sheng C
    J Med Chem; 2018 Mar; 61(6):2604-2610. PubMed ID: 29510040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.
    Cho KJ; Casteel DE; Prakash P; Tan L; van der Hoeven D; Salim AA; Kim C; Capon RJ; Lacey E; Cunha SR; Gorfe AA; Hancock JF
    Mol Cell Biol; 2016 Dec; 36(24):3086-3099. PubMed ID: 27697864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding site.
    Zimmermann G; Schultz-Fademrecht C; Küchler P; Murarka S; Ismail S; Triola G; Nussbaumer P; Wittinghofer A; Waldmann H
    J Med Chem; 2014 Jun; 57(12):5435-48. PubMed ID: 24884780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Biology-Inspired Discovery of Novel KRAS-PDEδ Inhibitors.
    Jiang Y; Zhuang C; Chen L; Lu J; Dong G; Miao Z; Zhang W; Li J; Sheng C
    J Med Chem; 2017 Nov; 60(22):9400-9406. PubMed ID: 28929751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.
    Niida A; Sasaki S; Yonemori K; Sameshima T; Yaguchi M; Asami T; Sakamoto K; Kamaura M
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2757-2761. PubMed ID: 28457754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-release alkylation of Asp12 enables mutant selective targeting of K-Ras-G12D.
    Zheng Q; Zhang Z; Guiley KZ; Shokat KM
    Nat Chem Biol; 2024 Sep; 20(9):1114-1122. PubMed ID: 38443470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of new Myo-inositol derivatives as potential RAS inhibitors.
    Hussain J; Chhabria D; Kirubakaran S
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127290. PubMed ID: 32631512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The KRAS-PDEδ interaction is a therapeutic target.
    Cancer Discov; 2013 Jul; 3(7):OF20. PubMed ID: 23847364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.